THERAPEUTIC SYNERGISM (TS) OF HOMOHARRINGTONINE (H) PLUS 5-FLUOROURACIL (FU) AGAINST LEUKEMIA P388 (P388/0) AND ARA-C-RESISTANT P388 (P388/ARA-C)

被引：0
|
作者：
LASTER, WR [1 ]
TRADER, MW [1 ]
SCHABEL, FM [1 ]
CORBETT, TH [1 ]
GRISWOLD, DP [1 ]
机构：
[1] SO RES INST,BIRMINGHAM,AL 35225
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1982年 / 23卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：199 / 199
页数：1
相关论文
共 50 条
  • [41] DEVELOPMENT AND CHARACTERIZATION OF A SUBLINE OF P388 LEUKEMIA RESISTANT TO BIS(DIPHENYLPHOSPHINO)ETHANE
    MCCABE, FL
    FAUCETTE, LF
    BARTUS, JO
    SUNG, CM
    JENSEN, BD
    RUSH, GF
    MIRABELLI, CK
    JOHNSON, RK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 315 - 315
  • [42] ASSESSMENT OF AURANOFINS ACTIVITY AGAINST THE MOUSE LYMPHOCYTIC-LEUKEMIA P388
    LORBER, A
    SIMON, TM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (02) : 262 - 262
  • [43] ANTICANCER ACTIVITY OF MOUSE INTERFERON (IFN) ALONE AND IN COMBINATION WITH CIS-DICHLORODIAMMINEPLATINUM II (CIS-DDPT) OR MITOMYCIN-C (MIT C) AGAINST LEUKEMIA P388 (P388) IN MICE
    SCHABEL, FM
    LASTER, WR
    TRADER, MW
    MOWSHOWITZ, SL
    SMITH, GD
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 190 - 190
  • [44] BEHAVIOR OF P388 MOUSE LEUKEMIA IN CHICK EMBRYO + HATCHED CHICK
    CLARKSON, B
    KARNOFSKY, DA
    KATZ, A
    DANN, MA
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1964, 32 (02) : 471 - &
  • [45] Tubulin isotypes in vinorelbine-resistant P388 leukemic cells
    Aggarwal, A
    Carter, BW
    Correia, JJ
    Frankfurter, A
    Hill, B
    Kruczynski, A
    Lobert, S
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 462A - 463A
  • [46] PHARMACOLOGICAL EVALUATION OF COMBINATION THERAPY OF P388 LEUKEMIA WITH CYCLOPHOSPHAMIDE AND PYRIMIDINONES
    LI, LH
    WALLACE, TL
    HAMILTON, RD
    DEKONING, TF
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1987, 9 (01): : 31 - 39
  • [47] DNA ALKYLATION BY MITOMYCIN-C IN P388 MURINE LEUKEMIA-CELLS
    IRACKI, T
    PAN, S
    BACHUR, NR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 213 - 213
  • [48] COMBINATION RADIOTHERAPY AND CHEMOTHERAPY FOR P388 LYMPHOCYTIC LEUKEMIA IN-VIVO
    WODINSKY, I
    SWINIARSKI, J
    KENSLER, CJ
    VENDITTI, JM
    CANCER CHEMOTHERAPY REPORTS PART 2 SUPPLEMENT, 1974, 4 (01): : 73 - 97
  • [49] COLLATERAL SENSITIVITY OF PALA IN P388 TUMOR RENDERED RESISTANT TO ACIVICIN
    YI, S
    ARDALAN, B
    JAYARAM, HN
    COONEY, DA
    MARQUEZ, V
    JOHNSON, RK
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 8 - 8
  • [50] DOXORUBICIN RESISTANCE IN P388 LEUKEMIA - EVIDENCE FOR REDUCED DRUG INFLUX
    RAMU, A
    POLLARD, HB
    ROSARIO, LM
    INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (03) : 539 - 547
12345